SCRS Talks

Medidata recently hosted a Site Advocacy Group (SAG) where SCRS member sites offered feedback on budgeting and payments for clinical trials. Tina Mincher, Director, Client Strategy, Clinical Trial Financial Management at Medidata and Edward Czerwinski, Senior Medical Director, FutureMeds, join us to discuss what was learned from a service provider and site perspective. Hear some of the top financi...

Amanda Wright​, Chief Development Officer at Javara , a new SCRS Global Impact Partner, shares insights about integrated research organizations (IROs), clinical research as a care option, and how industry partnerships can streamline clinical trials. Learn what initiatives Javara is working on and why joining SCRS was a priority for their organization.

SCRS is excited to welcome Transformative Pharmaceutical Solutions (TPS) to the Global Impact Partner program! Jeff Repper, Executive Vice President, and Kyle Given, EVP, Account Management share why their organization decided to become a GIP and how they want to work with clinical research sites and industry partners to improve the research experience for all.

Technology has the power to reduce the burden on overworked sites–but only if that technology is well-integrated. Catherine Gregor, Chief Clinical Trial Officer at Florence Healthcare , shares insights from her session at the 2022 Global Oncology Site Solutions Summit on challenges and opportunities with site-centric technology. Listen as Catherine shares how sites and Sponsors can ensure they are...

Commemorating a decade since the organization's inception , SCRS spoke with one of our first clinical research site members, Richard Pollack with Evolution Research Group.  Dr. Pollack shines a light on how he was introduced to SCRS and some of his fond memories with the organization while reflecting on how the industry has changed.

Decentralized clinical trial (DCT) technology has the opportunity to create more effective, efficient, and accessible clinical trials. Now that research sites have more experience with these systems, we also have a better understanding of their challenges and opportunities. Craig Lipset, advisor and founder of Clinical Innovation Partners and co-chair of the Decentralized Trials & Research All...

The clinical research industry is currently seeing an unprecedented rise of sites facing financial burden due to increasing costs of staffing and supplies. Now more than ever, it's critical that sites learn what actions they can take to ensure they understand what they are agreeing to in clinical trial agreements and what flexibility they have. Daniel Fox, Ph. D., founder and CEO of the Clini...

SCRS recently held its fourth annual Global Oncology Site Solutions Summit in Austin, Texas. It was an incredible two-day event with actionable insights and best practices specific to oncology clinical research. In this episode, we speak with Peter Fredette, a long-standing member of the SCRS Oncology program and our new Global Oncology Summit chair, to discuss some highlights from this year'...

Patient-centricity has been a hot topic in clinical research. Recently the industry has realized that to truly be patient-centric, you must also be site-centric. Deena Bernstein, Vice President of Customer Success at Datacubed, discusses what it means to be site and participant centric in clinical trials and how to reduce the burden of technology for both patients and sites.

The implementation of decentralized tools and technologies has drastically changed study start-up and training requirements that have placed an additional burden on clinical research sites. SCRS spoke with Todd Albin, CEO of Cedar Health Research to discuss how sites can prepare for these changes and ensure all industry stakeholders are working together to ensure efficiency and sustainability with...

The 2022 Australia-New Zealand Summit is quickly approaching! ANZ Summit chairs Cheryl-Ann Hawkins, Chief Operating Officer at Emeritus Research and Tam C. Nguyen, Deputy Director of Research at St. Vincent’s Hospital Melbourne, share what they are most excited about for this year's Summit, sessions they are looking forward to, and how to maximize your experience. Learn more and register toda...

Holdback payments evolved as a way for industry sponsors and CROs to ensure that their clinical research sites were completing the necessary work throughout a trial. However, holdback payments have been a long-standing issue for sites.  Vivienne van de Walle, co-founder of PreCare Trial & Recruitment, shares lessons learned from working with sponsors and CROs to eliminate this practice, and ti...

The industry is currently facing unprecedented macroeconomic issues including substantial staffing challenges and inflationary pressures.  In response, SCRS formed a task force committee , which provides resources for both sites and industry to collaborate to address these issues. David Vulcano, SCRS Honorary President and VP of Clinical Research Compliance & Integrity at HCA Healthcare speaks...

In this episode of SCRS Talks, we spoke with Jane Myles, VP of Clinical Trial Innovation at Curebase , a new Global Impact Partner. Jane shares what research sites should know about decentralized trial technology and some initiatives Curebase is working on that will impact sites.

Join SCRS in welcoming Clinical ink to the Global Impact Partner (GIP) program! Syed Faridi, Senior Director of Business Development, and Lane Nichols, Executive Vice President, Head of Product, share why they decided to become a GIP and what they see for the future of their relationship with clinical research sites.

This Clinical Trials Day is especially meaningful to SCRS because it is the same day as SCRS' first-ever Diversity Site Solutions Summit.   To share a preview of some of the critical discussions that we'll cover at the Summit, we are joined by Lorena Kuri from Bristol Myers Squibb, Lloryn Hubbard from PPD, and Jaleeysa King from Greenphire. We'll highlight some of the industry'...

Please join us in welcoming Aspen Insights to the SCRS Global Impact Partner program! Walter Storm, co-founder and CEO of Aspen Insights shares how his organization is listening to sites to understand their pain points and developing solutions to resolve them using data analytics. Listen to hear some initiatives Aspen Insights is working on to support site sustainability and streamlined trial enro...

In this episode, SCRS is excited to showcase H1 , one of SCRS' newest Global Impact Partners . We spoke with Adam Wyckoff, Director of Product Management, Clinical Trials, who shares why H1 believes listening to site voices is important and how they plan to work more closely with research sites in the future.  For more information about H1, please reach out to H1 at elizabeth.schwartz@h1.co.

SCRS is celebrating 10 years since our founder, Christine K. Pierre, officially formed the organization! We spoke with Clare Grace, Chief Patient Officer at one of SCRS' first Global Impact Partners , Parexel , to look back on why SCRS was created and how it has evolved through the years. We also explore current industry challenges SCRS is working to address, including how prioritizing site s...

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge , who shares more insight into this new law a...

Comprised of experienced and committed executives representing different segments of the clinical research industry, the SCRS Leadership Council provides strategic guidance, policy decisions and oversight to SCRS. Our newest Leadership Council member Mohammad A. Millwala, CEO of DM Clinical Research , shares how he initially became involved with SCRS,  industry initiatives he is excited to work on...

In this episode, we're discussing a new U.S. law condition that states Medicaid is to cover the trial-related routine care costs for Medicaid beneficiaries in clinical trials. Effective January 2022, there is a new form for principal investigators to use in these instances to secure Medicaid coverage, creating an additional and potentially burdensome step for research sites and patients with...

In February 2022, the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act was submitted to legislation. Kim Kundert, Sr. Vice President of Site Development Services at Total Diversity Clinical Trial Management, joins us to discuss how the industry can prepare for upcoming changes surrounding diverse patient participation in clinical research. Learn more about the DEPICT Act: https:...

As many organizations within the clinical research industry search for candidates, many want to work with those they already know. Unfortunately, this means some CROs and sponsors are asking site staff to come and work for their organizations instead.  Karri Venn, Chief Operating Officer, President, and Chair of the Operating Board at Centricity Research discusses her experience with site staff po...

Collaborating with other sites can expand your site's opportunities and revenue significantly when done right. Kay Scroggins, Steve Satek, and Ana Marquez discuss why they founded their new site network, Flourish Research , and advice they have for other sites looking to expand, sell or collaborate with one another. Find out how your site can grow through partnerships in this episode.